肺动脉肉瘤与中转移:一个病例报告
Jin Cai1, Bin Nan2, Fangbin Liu1
1Department of Radiology, Central China Subcenter of National Center for Cardiovascular Diseases, Fuwai Central China Cardiovascular Hospital, Central China Fuwai Hospital of Zhengzhou University, Zhengzhou, China.
肺动脉肉瘤可以扩散到中间体,导致动脉入侵和动脉瘤. 双能量CT (DECT) 对于诊断这种罕见的疾病及其并发症至关重要.
科学领域:
- 心血管成像 - 心血管成像
- 胸部瘤学 胸部瘤学
- 血管病理学血管病理学
背景情况:
- 肺动脉肉瘤是一种罕见且具有攻击性的恶性瘤.
- 肺动脉肉瘤的转移性传播可以呈现出复杂的血管表现.
- 正确的诊断是具有挑战性的,因为稀有和多样化的呈现.
研究的目的:
- 报告一个肺动脉肉瘤病例与中枢膜转移和动脉动脉瘤.
- 突出双能CT (DECT) 在识别肺动脉肉瘤及其并发症方面的诊断实用性.
- 为了说明转移性病变侵入肺动脉并引起动脉瘤的可能性.
主要方法:
- 一名67岁的男性患者持续咳和胸痛,接受了双能量CT (DECT) 和肺血管造影.
- DECT用于评估肺动脉的填充缺陷,中质,以及肺动脉动脉瘤.
- 为了确定确诊,进行了肺动脉活检,并为肺腔化进行了抗真菌治疗.
主要成果:
- DECT揭示了肺动脉填充缺陷,具有匹配的光谱特征的中质量,左肺动脉动脉瘤和右肺腔化.
- 肺动脉活检证实了无差异的肺动脉肉瘤.
- 肺血管造影证实左肺动脉多重动脉瘤,抗真菌治疗改善了肺腔位.
结论:
- 肺动脉肉瘤可以转移到中,侵入邻近的动脉,导致动脉瘤的形成.
- DECT是诊断肺动脉肉瘤,评估其程度以及识别动脉瘤等血管并发症的关键成像模式.
- 这一案例强调了在复杂胸部病理的差异诊断中考虑罕见恶性瘤的重要性.
更多相关视频
08:17Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
07:02A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep
Published on: July 15, 2021
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Data Reporting and Recording
